Suppr超能文献

基于三氧化二铋碘化物的复合材料在药物矿化中用于高级可见光激活过一硫酸盐。

Bismuth oxyiodide-based composites for advanced visible-light activation of peroxymonosulfate in pharmaceutical mineralization.

机构信息

Grup d'Electrodeposició de Capes Primes i Nanoestructures (GE-CPN), Departament de Ciència de Materials i Química Física, Universitat de Barcelona, Martí i Franquès, 1, E-08028, Barcelona, Catalonia, Spain; Institute of Nanoscience and Nanotechnology (IN(2)UB), Universitat de Barcelona, Barcelona, Catalonia, Spain.

Grup d'Electrodeposició de Capes Primes i Nanoestructures (GE-CPN), Departament de Ciència de Materials i Química Física, Universitat de Barcelona, Martí i Franquès, 1, E-08028, Barcelona, Catalonia, Spain.

出版信息

Chemosphere. 2024 Oct;366:143532. doi: 10.1016/j.chemosphere.2024.143532. Epub 2024 Oct 12.

Abstract

The presence of pharmaceutical pollutants in water bodies represents a significant environmental and public health concern, largely due to their inherent persistence and potential to induce antibiotic resistance. Advanced oxidation processes (AOPs) that employ peroxymonosulfate (PMS) activation have emerged as an effective means of degrading these contaminants. Bismuth oxyiodides (BiOI), which are known for their visible-light photocatalytic properties, demonstrate considerable potential for removal of pharmaceutical pollutants. This study examines the synthesis and performance of BiOI-based composites with barium ferrite (BFO) nanoparticles for enhanced PMS activation under visible light. BiOI and BiOI were synthesized via solvothermal and electrodeposition methods, respectively, and their morphologies and crystalline structures were observed to exhibit distinctive characteristics following annealing. The formation of the composite with BFO resulted in an improvement in the catalytic properties, which in turn enhanced the surface area and availability of active sites. The objective of the photocatalytic studies was to evaluate the degradation and mineralization of tetracycline (TC) under visible light, PMS, and combined conditions. The BiOI(ED)-BFO catalyst was identified as the optimal candidate, achieving up to 99.8% TC degradation and 99.4% mineralization within 90 min at room temperature. The synergistic effect of BFO in BiOI-based composites significantly enhanced performance across all conditions, indicating their potential for efficient remediation of pharmaceutical pollutant. The material's performance was further evaluated in tap water, where the degradation efficiency decreased to 56.4% and mineralization to 38.2%. These results reflect the challenges posed by complex water matrices. However, doubling the PMS concentration to 5 mM led to improved outcomes, with 93.8% degradation and 81.4% mineralization achieved. These findings demonstrate the material's robust potential for treating pharmaceutical pollutants in real-world conditions, advancing sustainable water treatment technologies.

摘要

水体中药物污染物的存在是一个重大的环境和公共卫生问题,主要是因为它们具有固有持久性和诱导抗生素耐药性的潜力。过一硫酸盐(PMS)活化的高级氧化工艺(AOPs)已成为降解这些污染物的有效方法。具有可见光光催化性能的铋碘氧化物(BiOI)在去除药物污染物方面具有很大的潜力。本研究考察了基于 BiOI 的复合材料与钡铁氧体(BFO)纳米粒子的合成和性能,以在可见光下增强 PMS 的活化。BiOI 和 BiOI 分别通过溶剂热法和电沉积法合成,观察到它们的形态和晶体结构在退火后表现出独特的特征。与 BFO 形成的复合材料提高了催化性能,从而提高了比表面积和活性位点的可用性。光催化研究的目的是评估四环素(TC)在可见光、PMS 和组合条件下的降解和矿化。BiOI(ED)-BFO 催化剂被鉴定为最佳候选物,在室温下 90 分钟内达到高达 99.8%的 TC 降解和 99.4%的矿化。BFO 在 BiOI 基复合材料中的协同作用显著提高了所有条件下的性能,表明它们具有有效修复药物污染物的潜力。在自来水中进一步评估了该材料的性能,降解效率降低至 56.4%,矿化率降低至 38.2%。这些结果反映了复杂水基质带来的挑战。然而,将 PMS 浓度提高到 5mM 可改善结果,实现 93.8%的降解和 81.4%的矿化。这些发现表明,该材料在实际条件下处理药物污染物具有强大的潜力,推进了可持续的水处理技术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验